Ligand discovers, develops and markets new drugs for critical unmet medical needs in the areas of cancer, pain, skin diseases, hormone related diseases, osteoporosis, metabolic disorders, cardiovascular and inflammatory diseases. Ligand s proprietary drug discovery and development programs are based on its leadership position in gene transcription technology related to intracellular receptors.
Quote | Ligand Pharmaceuticals Inc General Contingent Value Rt (OTCMKTS:LGNYZ)
Last: | $0.00638 |
---|---|
Change Percent: | 0.0% |
Open: | $0.00638 |
Close: | $0.00638 |
High: | $0.00638 |
Low: | $0.00638 |
Volume: | 250 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
News | Ligand Pharmaceuticals Inc General Contingent Value Rt (OTCMKTS:LGNYZ)
2024-04-25 10:05:00 ET Summary Tourlite Capital Management, LP is an asset management firm focused on long/short equity investing in public companies. Tourlite Fund, LP returned 6.0% for the First Quarter of 2024. The Fund has annualized returns of 10.0% since inception, compa...
2023-11-08 22:22:05 ET Ligand Pharmaceuticals Inc. (LGND) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Simon Latimer - Head-Investor Relations Todd Davis - Chief Executive Officer Matthew Korenberg - President and Chief Operat...
Message Board Posts | Ligand Pharmaceuticals Inc General Contingent Value Rt (OTCMKTS:LGNYZ)
Subject | By | Source | When |
---|---|---|---|
This board was closed to posting as part | IH Geek [Dave] | investorshub | 04/04/2020 2:19:10 PM |
;) thank god | $theDDmessiah | investorshub | 04/04/2020 12:35:23 PM |
Excellent DD... This is no scam stinky pinky | Thehustle | investorshub | 04/04/2020 12:30:42 PM |
If I didnt trade and invest Id be | $theDDmessiah | investorshub | 04/04/2020 12:04:53 PM |
Hows the weather up north? | $theDDmessiah | investorshub | 04/04/2020 12:03:54 PM |